Robert A. Livingston

614 total citations
15 papers, 386 citations indexed

About

Robert A. Livingston is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Robert A. Livingston has authored 15 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Virology and 5 papers in Immunology. Recurrent topics in Robert A. Livingston's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Robert A. Livingston is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Robert A. Livingston collaborates with scholars based in United States and Puerto Rico. Robert A. Livingston's co-authors include Diane W. Wara, Stuart C. Ray, Elizabeth Rubalcaba, Stephen A. Spector, Raphael P. Viscidi, Yvonne J. Bryson, N. Strunnikova, Jay A. Perman, José M. Saavedra and Robin A. Henderson and has published in prestigious journals such as New England Journal of Medicine, Cancer and Journal of Virology.

In The Last Decade

Robert A. Livingston

15 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Livingston United States	10	190	178	127	84	60	15	386
Ermias Hailu Ethiopia	6	180 0.9×	161 0.9×	92 0.7×	137 1.6×	65 1.1×	7	418
Maadhava Ellaurie United States	13	213 1.1×	203 1.1×	158 1.2×	101 1.2×	74 1.2×	27	463
Elvia Palomba Italy	9	122 0.6×	102 0.6×	249 2.0×	45 0.5×	45 0.8×	11	396
C A Lee United Kingdom	7	119 0.6×	145 0.8×	109 0.9×	60 0.7×	39 0.7×	11	370
Enzo Raise Italy	11	138 0.7×	73 0.4×	205 1.6×	62 0.7×	32 0.5×	27	369
PM Girard France	12	238 1.3×	192 1.1×	145 1.1×	74 0.9×	79 1.3×	37	525
Paul D. Griffiths United Kingdom	7	148 0.8×	265 1.5×	362 2.9×	260 3.1×	67 1.1×	10	662
Eva Stylianou Norway	7	97 0.5×	201 1.1×	94 0.7×	214 2.5×	61 1.0×	12	411
Sabine Kinloch‐de Loes United Kingdom	12	439 2.3×	458 2.6×	156 1.2×	91 1.1×	82 1.4×	32	628
Alejandro Gómez-Delgado Mexico	15	119 0.6×	58 0.3×	134 1.1×	73 0.9×	10 0.2×	21	494

Countries citing papers authored by Robert A. Livingston

Since Specialization

Citations

This map shows the geographic impact of Robert A. Livingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Livingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Livingston more than expected).

Fields of papers citing papers by Robert A. Livingston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Livingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Livingston. The network helps show where Robert A. Livingston may publish in the future.

Co-authorship network of co-authors of Robert A. Livingston

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Livingston. A scholar is included among the top collaborators of Robert A. Livingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Livingston. Robert A. Livingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Masárová, Lucia, John Mascarenhas, Raajit K. Rampal, et al.. (2024). Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety. Cancer. 131(1). e35661–e35661. 4 indexed citations

2.

Hu, Wilson, et al.. (2024). Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year. American Journal of Clinical Dermatology. 25(2). 327–332. 9 indexed citations

3.

Verstovšek, Srđan, Ruben A. Mesa, Robert A. Livingston, Wilson Hu, & John Mascarenhas. (2023). Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety. Journal of Hematology & Oncology. 16(1). 82–82. 24 indexed citations

4.

McFarland, Elizabeth J., William Borkowsky, Terry Fenton, et al.. (2001). Human Immunodeficiency Virus Type 1 (HIV‐1) gp120–Specific Antibodies in Neonates Receiving an HIV‐1 Recombinant gp120 Vaccine. The Journal of Infectious Diseases. 184(10). 1331–1335. 43 indexed citations

5.

Lambert, John S., James McNamara, Samuel L. Katz, et al.. (1998). Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(5). 451–461. 25 indexed citations

6.

Livingston, Robert A., et al.. (1997). Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase. Journal of Virology. 71(12). 9524–9530. 24 indexed citations

7.

Saavedra, José M., et al.. (1996). Enteric pathogens associated with gastrointestinal dysfunction in children with HIV infection. Molecular and Cellular Probes. 10(2). 67–73. 11 indexed citations

8.

Lambert, John S., James McNamara, Samuel L. Katz, Robert A. Livingston, & Jack Moye. (1996). SAFETY AND IMMUNOGENICITY OF HIV RECOMBINANT ENVELOPE VACCINES IN HIV-INFECTED INFANTS AND CHILDREN. † 57. Pediatric Research. 39. 12–12. 2 indexed citations

9.

Livingston, Robert A.. (1995). Human Immunodeficiency Virus-Specific IgA in Infants Born to Human Immunodeficiency Virus-Seropositive Women. Archives of Pediatrics and Adolescent Medicine. 149(5). 503–503. 9 indexed citations

10.

Willoughby, Rodney E. & Robert A. Livingston. (1995). Approach to the HIV-infected child with diarrhea. Seminars in Pediatric Infectious Diseases. 6(1). 17–25. 1 indexed citations

11.

Strunnikova, N., Stuart C. Ray, Robert A. Livingston, Elizabeth Rubalcaba, & Raphael P. Viscidi. (1995). Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. Journal of Virology. 69(12). 7548–7558. 55 indexed citations

12.

Henderson, Robin A., José M. Saavedra, Jay A. Perman, et al.. (1994). Effect of Enteral Tube Feeding on Growth of Children with Symptomatic Human Immunodeficiency Virus Infection. Journal of Pediatric Gastroenterology and Nutrition. 18(4). 429–434. 49 indexed citations

13.

Spector, Stephen A., Richard D. Gelber, Nuala McGrath, et al.. (1994). A Controlled Trial of Intravenous Immune Globulin for the Prevention of Serious Bacterial Infections in Children Receiving Zidovudine for Advanced Human Immunodeficiency Virus Infection. New England Journal of Medicine. 331(18). 1181–1187. 90 indexed citations

14.

Henderson, Robin A., José M. Saavedra, Jay A. Perman, et al.. (1994). Effect of Enteral Tube Feeding on Growth of Children with Symptomatic Human Immunodeficiency Virus Infection. Journal of Pediatric Gastroenterology and Nutrition. 18(4). 429–434. 4 indexed citations

15.

Quinn, Thomas C., et al.. (1993). Acid Dissociation of Immune Complexes Improves Diagnostic Utility of p24 Antigen Detection in Perinatally Acquired Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 167(5). 1193–1193. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact